Assuntos
Betacoronavirus/isolamento & purificação , Técnicas de Laboratório Clínico , Infecções por Coronavirus/diagnóstico , Monitoramento Epidemiológico , Pneumonia Viral/diagnóstico , Guias de Prática Clínica como Assunto , Cuidados Pré-Operatórios/normas , Reação em Cadeia da Polimerase Via Transcriptase Reversa/normas , Adulto , Idoso , COVID-19 , Teste para COVID-19 , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pandemias , Medição de Risco/normas , SARS-CoV-2 , Inquéritos e QuestionáriosRESUMO
INTRODUCTION: The COVID-19 pandemic is changing approaches to diagnosis, treatment, and care provision in multiple sclerosis (MS). During both the initial and peak phases of the epidemic, the administration of disease-modifying drugs, typically immunosuppressants administered in pulses, was suspended due to the uncertainty about their impact on SARS-CoV-2 infection, mainly in contagious asymptomatic/presymptomatic patients. The purpose of this study is to present a safety algorithm enabling patients to resume pulse immunosuppressive therapy (PIT) during the easing of lockdown measures. METHODS: We developed a safety algorithm based on our clinical experience with MS and the available published evidence; the algorithm assists in the detection of contagious asymptomatic/presymptomatic cases and of patients with mild symptoms of SARS-CoV-2 infection with a view to withdrawing PIT in these patients and preventing new infections at day hospitals. RESULTS: We developed a clinical/microbiological screening algorithm consisting of a symptom checklist, applied during a teleconsultation 48hours before the scheduled session of PIT, and PCR testing for SARS-CoV-2 in nasopharyngeal exudate 24hours before the procedure. CONCLUSION: The application of our safety algorithm presents a favourable risk-benefit ratio despite the fact that the actual proportion of asymptomatic and presymptomatic individuals is unknown. Systematic PCR testing, which provides the highest sensitivity for detecting presymptomatic cases, combined with early detection of symptoms of SARS-CoV-2 infection may reduce infections and improve detection of high-risk patients before they receive PIT.
Assuntos
Algoritmos , Betacoronavirus/isolamento & purificação , Infecções por Coronavirus/prevenção & controle , Imunossupressores/administração & dosagem , Esclerose Múltipla/tratamento farmacológico , Pandemias/prevenção & controle , Pneumonia Viral/prevenção & controle , Assistência Ambulatorial , Doenças Assintomáticas , COVID-19 , Teste para COVID-19 , Lista de Checagem , Técnicas de Laboratório Clínico , Contraindicações de Medicamentos , Infecções por Coronavirus/diagnóstico , Suscetibilidade a Doenças , Humanos , Hospedeiro Imunocomprometido , Imunossupressores/efeitos adversos , Imunossupressores/uso terapêutico , Programas de Rastreamento/métodos , Nasofaringe/virologia , Pneumonia Viral/diagnóstico , Reação em Cadeia da Polimerase , Pulsoterapia , Quarentena , Medição de Risco , SARS-CoV-2 , Avaliação de Sintomas , TelemedicinaRESUMO
In order to investigate the etiology of viral neurological infections in Spain, a national study was performed in 2008. The results obtained have been published. Enteroviruses were the most frequent cause of the aseptic meningitis and infant febrile syndromes. The present report supplements the previous study with the genotyping of the detected enteroviruses. Typing was by amplification of partial VP1 region and sequencing in 70 (53%) of the 132 available cerebrospinal fluid samples positive for enteroviruses. Twelve different genotypes within the B species were identified. Echovirus 4 was predominant (24%), followed by echovirus 30 (19%), echovirus 9 (17%), and echovirus 6 (14%). In summary, a co-circulation of several enterovirus types associated with meningitis in children under 15 years old was observed. Although infrequently detected, echovirus 4 was the predominant genotype identified due to an aseptic meningitis outbreak which occurred in the Canary Islands in 2008.
Assuntos
Infecções por Enterovirus/virologia , Enterovirus/classificação , Enterovirus/genética , Meningite Asséptica/virologia , Adolescente , Adulto , Líquido Cefalorraquidiano/virologia , Criança , Pré-Escolar , Enterovirus/isolamento & purificação , Infecções por Enterovirus/epidemiologia , Genótipo , Humanos , Lactente , Recém-Nascido , Masculino , Meningite Asséptica/epidemiologia , Pessoa de Meia-Idade , Prevalência , RNA Viral/genética , Análise de Sequência de DNA , Espanha/epidemiologia , Proteínas Estruturais Virais/genética , Adulto JovemRESUMO
OBJECTIVES: To describe the epidemiology, clinical characteristics and treatments prescribed in children with bronchiolitis admitted to our hospital. MATERIAL AND METHODS: Observational, descriptive and prospective study of children younger than 18 months, admitted to Hospital Virgen de la Arrixaca of Murcia (Spain), with the diagnosis of bronchiolitis, during the season of maximum incidence (December 2008-April 2009). RESULTS: A total of 235 infants were admitted, of whom 78.7% of them were aged 5 months or less. We found a positive correlation between the number of cigarettes smoked by their mothers during pregnancy and the number of hospitalization and oxygen therapy days. Children whose mothers were smokers at the time of their admission needed a greater number of oxygen therapy days. Also infants who were not breastfed needed oxygen therapy during more days. Just under one quarter (23.8%) of them had underlying diseases, with prematurity being the most frequent and a risk factor for the ongoing of oxygen therapy and hospital stay. The use of diagnostic tests, bronchodilators, corticosteroids and antibiotics was high. The onset of high temperature was associated with an increased use of antibiotics in outside and inside the hospital setting. An abnormal chest X-ray or a raised C-reactive protein was associated with a higher use of antibiotics. Respiratory Syncytial virus (RSV) was the main aetiological agent, followed by Rhinovirus, Bocavirus, Adenovirus and Metapneumovirus CONCLUSIONS: The majority of hospital admissions due to bronchiolitis took place during the first months of life. Infants whose mothers smoked during pregnancy had a worse clinical outcome. Despite the availability of clinical practice guidelines in our area, the use of diagnostic tests and pharmacological treatment was high.
Assuntos
Bronquiolite Viral , Bronquiolite Viral/diagnóstico , Bronquiolite Viral/epidemiologia , Bronquiolite Viral/etiologia , Bronquiolite Viral/terapia , Feminino , Hospitalização , Humanos , Lactente , Masculino , Estudos Prospectivos , Fatores de RiscoRESUMO
BACKGROUND: Bronchiolitis is the most common respiratory disease in children under 2 years-old and a major cause of hospitalization in young children, especially during the winter. OBJECTIVES: To determine the prevalence and etiology of bronchiolitis in south-east of Spain. STUDY DESIGN: A prospective study was conducted during the bronchiolitis season (December-April). Children below 18 months-old admitted to the hospital for a first bronchiolitis episode were included. Nasopharyngeal aspirates were analysed by reverse transcription polymerase chain reaction (RT-PCR) respiratory syncytial virus. RESULTS: A total of 235 children were included during this period, and 235 RT-PCR were performed. A total of 287 viruses were detected in nasopharyngeal aspirates from 204 infants. Respiratory syncytial virus was the virus detected more frequently, followed by rhinovirus. Co-infections were found in the 36% of children. CONCLUSIONS: Respiratory viruses were detected in most of the children below 18 months-old hospitalised with bronchiolitis, and 36% of them showed a mixed infection.